Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7

Detalhes bibliográficos
Autor(a) principal: Jung, Ivo Emilio da Cruz
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
dARK ID: ark:/26339/001300000j7kk
Texto Completo: http://repositorio.ufsm.br/handle/1/28154
Resumo: Introduction: Antipsychotic drugs, such as haloperidol (typical) and risperidone (atypical) increase the risk of obesity and other endocrine disturbs in psychiatric patients when used in long term treatments. There is some evidence that suggest that the proinflammatory effect of these drugs could contribute to the stablishement of these morbidities. However, the results obtained until now are contradictory. For this reason, investigaions using isolated cells from the immune system that are directly involved with inflammatory procecesss are considered relevant. Objective: The present study investigated the in vitro effect of three haloperidol and risperidone concentrations (20, 30 e 40 μM) on RAW 264.7 cell line macrophages for analysis of morphologicl pattern, oxide nitric levels, cell viability (24, 48 and 72 h), apoptosis induction and cytokine production. Methods: Macrophage cell culture was made in RPMI 1640 medium, 10% fetal bovine serum, 1% antibiotics in CO2 % incubator at 37oC. The nitric oxide (NO) levels were determined by Griess assay modified to measure nitrite/nitrate ratio by spectrophotometry. Apoptosis was determined by flow cytometry using Annexin V and iodide propidium as cell markers. Gene expression analysis of Bcl-2 and BAX genes were performed by QT-PCR was well as quantification of caspases 8 and 3 levels were performed by ELISA immunoassay. Treatments were compared by One-way analysis of variance followed by Tukey or Dunnet post hoc test. Results: Macrophages exposed to different concentrations of haloperidol and risperidone presented increased NO levels, morphological alterations as well as decrease in viability after 24, 48 and 72 h of exposition. The apoptosis level of cells was significantly higher than untreated cells when macrophages were exposed to haloperidol (40μM) and all treatments with risperidone after 24 h exposition. Bcl-2/BAX ratio gene expression was downregulated in cells exposed to haloperidol and risperidone confirming apoptosis induction by these drugs. Caspases 8 and 3 levels also increased in a dose-depend way. The inflammatory cytokine levels increased in all treatments (IL-1β, IL- 6,TNFα, INFγ) whereas IL-10 levels, a antiinflammatory cytokine decreased. Conclusion: The whole of results suggest that haloperidol and risperidone act directly on macrophages and can exacerbate inflammatory processes. The inflammatory mechanism of these actions can influence the development of obesity in patients that make long term use of these drugs.
id UFSM_9e72daf45bbbd887536d4a40b7c1622c
oai_identifier_str oai:repositorio.ufsm.br:1/28154
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7AntipsicóticosInflamaçãoMacrófagosApoptoseCitocinasAntipsychoticsInflammationMacrophagesApoptosisCitokinesCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAIntroduction: Antipsychotic drugs, such as haloperidol (typical) and risperidone (atypical) increase the risk of obesity and other endocrine disturbs in psychiatric patients when used in long term treatments. There is some evidence that suggest that the proinflammatory effect of these drugs could contribute to the stablishement of these morbidities. However, the results obtained until now are contradictory. For this reason, investigaions using isolated cells from the immune system that are directly involved with inflammatory procecesss are considered relevant. Objective: The present study investigated the in vitro effect of three haloperidol and risperidone concentrations (20, 30 e 40 μM) on RAW 264.7 cell line macrophages for analysis of morphologicl pattern, oxide nitric levels, cell viability (24, 48 and 72 h), apoptosis induction and cytokine production. Methods: Macrophage cell culture was made in RPMI 1640 medium, 10% fetal bovine serum, 1% antibiotics in CO2 % incubator at 37oC. The nitric oxide (NO) levels were determined by Griess assay modified to measure nitrite/nitrate ratio by spectrophotometry. Apoptosis was determined by flow cytometry using Annexin V and iodide propidium as cell markers. Gene expression analysis of Bcl-2 and BAX genes were performed by QT-PCR was well as quantification of caspases 8 and 3 levels were performed by ELISA immunoassay. Treatments were compared by One-way analysis of variance followed by Tukey or Dunnet post hoc test. Results: Macrophages exposed to different concentrations of haloperidol and risperidone presented increased NO levels, morphological alterations as well as decrease in viability after 24, 48 and 72 h of exposition. The apoptosis level of cells was significantly higher than untreated cells when macrophages were exposed to haloperidol (40μM) and all treatments with risperidone after 24 h exposition. Bcl-2/BAX ratio gene expression was downregulated in cells exposed to haloperidol and risperidone confirming apoptosis induction by these drugs. Caspases 8 and 3 levels also increased in a dose-depend way. The inflammatory cytokine levels increased in all treatments (IL-1β, IL- 6,TNFα, INFγ) whereas IL-10 levels, a antiinflammatory cytokine decreased. Conclusion: The whole of results suggest that haloperidol and risperidone act directly on macrophages and can exacerbate inflammatory processes. The inflammatory mechanism of these actions can influence the development of obesity in patients that make long term use of these drugs.Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqIntrodução: Fármacos antipsicóticos, como o haloperidol (típico) e a risperidona (atípico) quando utilizados por muito tempo podem aumentar o risco de obesidade e de outras disfunções endócrinas em pacientes psiquiátricos. Existem algumas evidências que sugerem que estes fármacos possuem efeito pró-inflamatório, o que contribuiria para o estabelecimento destes distúrbios. Entretanto, os resultados obtidos até o presente momento são bastante contraditórios. Por este motivo, investigações em células isoladas do sistema imune que estão diretamente envolvidas com o processo inflamatório são relevantes. Objetivos: O presente estudo teve como objetivo principal investigar o efeito in vitro de três concentrações de haloperidol e risperidona (20, 30 e 40 μM) na ativação de macrófagos da linhagem RAW 264.7 através da análise de padrões de alteração morfológica celular, níveis de oxido nítrico, viabilidade 24, 48 e 72 h após a exposição, indução a apoptose e produção de citocinas inflamatórias e pró-inflamatórias. Métodos: A cultura dos macrófagos foi realizada em meio RPMI 1640, suplementado com 10% de soro bovino fetal e 1% antibióticos, em estufa de CO2 (5%) a 37o C. Os níveis de oxido nítrico foram determinados por técnica de Griess modificada que mede a taxa de nitrito/nitrato por espectrofotometria; a viabilidade celular foi determinada pelo ensaio espectrofotométrico do MTT; a apoptose foi analisada por citometria de fluxo com marcação celular da anexina V e iodeto de propídio. Análise da expressão do gene antiapoptótico Bcl-2 e pró-apoptótico BAX foi realizada via QT- PCR bem como a quantificação das caspases 3 e 8 foi realizada através da técnica de imunoensaio ELISA. Os tratamentos foram comparados por análise de variância de uma via seguida de teste post hoc de Tukey ou de Dunnet, através do Software Graph Pad Prism 5.0. Resultados: Macrófagos expostos a diferentes concentrações de haloperidol e risperidona apresentaram aumento nos níveis de oxido nítrico, alterações morfológicas e diminuição na viabilidade após 24, 48 e 72 h de exposição. Os níveis de células em apoptose inicial foram significativamente mais elevados em células tratadas com haloperidol (40μM) e em todos os tratamentos com risperidona após 24 horas de exposição. A razão Bcl-2/BAX foi menor que 1 em em células tratadas com os fármacos antipsicóticos indicando indução apoptótica. Os níveis de caspases 3 e 8 também se elevaram de um modo dose-dependente. Os níveis de citocinas inflamatórias aumentaram em todos os tratamentos (IL-1β, IL-6,TNFα, INFγ) enquanto os níveis de IL-10, que é uma citocina anti-inflamatória diminuíram. Conclusão: O conjunto dos resultados sugere que o haloperidol e risperidona agem diretamente sobre os macrófagos e que podem exacerbar processos inflamatórios. A ação no metabolismo inflamatório destes fármacos parece influenciar no desenvolvimento da obesidade de pacientes que usam estes medicamentos por um longo tempo.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeMoresco, Rafael Noalhttp://lattes.cnpq.br/2269922709577261Duarte, Marta Maria Medeiros FrescuraBauermann, LilianeMontano, Marco Aurélio EchartJung, Ivo Emilio da Cruz2023-03-10T15:54:11Z2023-03-10T15:54:11Z2015-04-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/28154ark:/26339/001300000j7kkporAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2023-03-10T15:54:11Zoai:repositorio.ufsm.br:1/28154Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2023-03-10T15:54:11Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
title Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
spellingShingle Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
Jung, Ivo Emilio da Cruz
Antipsicóticos
Inflamação
Macrófagos
Apoptose
Citocinas
Antipsychotics
Inflammation
Macrophages
Apoptosis
Citokines
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
title_full Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
title_fullStr Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
title_full_unstemmed Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
title_sort Efeito in vitro do haloperidol e risperidona na ativação inflamatória de macrófagos RAW 264.7
author Jung, Ivo Emilio da Cruz
author_facet Jung, Ivo Emilio da Cruz
author_role author
dc.contributor.none.fl_str_mv Moresco, Rafael Noal
http://lattes.cnpq.br/2269922709577261
Duarte, Marta Maria Medeiros Frescura
Bauermann, Liliane
Montano, Marco Aurélio Echart
dc.contributor.author.fl_str_mv Jung, Ivo Emilio da Cruz
dc.subject.por.fl_str_mv Antipsicóticos
Inflamação
Macrófagos
Apoptose
Citocinas
Antipsychotics
Inflammation
Macrophages
Apoptosis
Citokines
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Antipsicóticos
Inflamação
Macrófagos
Apoptose
Citocinas
Antipsychotics
Inflammation
Macrophages
Apoptosis
Citokines
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Introduction: Antipsychotic drugs, such as haloperidol (typical) and risperidone (atypical) increase the risk of obesity and other endocrine disturbs in psychiatric patients when used in long term treatments. There is some evidence that suggest that the proinflammatory effect of these drugs could contribute to the stablishement of these morbidities. However, the results obtained until now are contradictory. For this reason, investigaions using isolated cells from the immune system that are directly involved with inflammatory procecesss are considered relevant. Objective: The present study investigated the in vitro effect of three haloperidol and risperidone concentrations (20, 30 e 40 μM) on RAW 264.7 cell line macrophages for analysis of morphologicl pattern, oxide nitric levels, cell viability (24, 48 and 72 h), apoptosis induction and cytokine production. Methods: Macrophage cell culture was made in RPMI 1640 medium, 10% fetal bovine serum, 1% antibiotics in CO2 % incubator at 37oC. The nitric oxide (NO) levels were determined by Griess assay modified to measure nitrite/nitrate ratio by spectrophotometry. Apoptosis was determined by flow cytometry using Annexin V and iodide propidium as cell markers. Gene expression analysis of Bcl-2 and BAX genes were performed by QT-PCR was well as quantification of caspases 8 and 3 levels were performed by ELISA immunoassay. Treatments were compared by One-way analysis of variance followed by Tukey or Dunnet post hoc test. Results: Macrophages exposed to different concentrations of haloperidol and risperidone presented increased NO levels, morphological alterations as well as decrease in viability after 24, 48 and 72 h of exposition. The apoptosis level of cells was significantly higher than untreated cells when macrophages were exposed to haloperidol (40μM) and all treatments with risperidone after 24 h exposition. Bcl-2/BAX ratio gene expression was downregulated in cells exposed to haloperidol and risperidone confirming apoptosis induction by these drugs. Caspases 8 and 3 levels also increased in a dose-depend way. The inflammatory cytokine levels increased in all treatments (IL-1β, IL- 6,TNFα, INFγ) whereas IL-10 levels, a antiinflammatory cytokine decreased. Conclusion: The whole of results suggest that haloperidol and risperidone act directly on macrophages and can exacerbate inflammatory processes. The inflammatory mechanism of these actions can influence the development of obesity in patients that make long term use of these drugs.
publishDate 2015
dc.date.none.fl_str_mv 2015-04-10
2023-03-10T15:54:11Z
2023-03-10T15:54:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/28154
dc.identifier.dark.fl_str_mv ark:/26339/001300000j7kk
url http://repositorio.ufsm.br/handle/1/28154
identifier_str_mv ark:/26339/001300000j7kk
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1815172348990455808